Similar to This
Bernd Förtsch on BioNTech: Resignation is overdue
Bernd Förtsch on BioNTech: Resignation is overdue: Shareholder Bernd Förtsch sharply criticizes the events at the Corona superstar.
deraktionaer.de/artikel/aktien/bernd-foertsch-ueber-biontech-ruecktritt-ist-ueberfaellig-20409989.html
BioNTech in Marburg: Plant closure as a warning signal
OpinionBioNTech in Marburg: Plant closure as a warning signal: The BioNTech site in Marburg once helped to ramp up vaccine production during the pandemic ...
faz.net/aktuell/rhein-main/biontech-in-marburg-werksschliessung-als-warnsignal-201271676.html
Three German BioNTech plants must close
Three German BioNTech plants must close: Three German production sites of the pharmaceutical company BioNTech will be closed. The plants in Marburg ...
tagesschau.de/wirtschaft/unternehmen/biontech-standorte-schliessung-100.html
BioNTech: Triple buy recommendation - | is it starting now?
BioNTech: Triple buy recommendation - | is it starting now?: BioNTech receives positive analyst opinions after promising studies on Gotistobart and a combination ...
deraktionaer.de/artikel/pharma-biotech/biontech-dreifache-kaufempfehlung-gehts-jetzt-los-20408884.html
mRNA cancer vaccine: After soaring high, setback for Mainz-based BioNTech
mRNA cancer vaccine: After soaring high, setback for Mainz-based BioNTech: After strong test data from its US competitor Moderna, BioNTech's stock price shot ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/mrna-krebsimpfstoff-nach-hoehenflug-rueckschlag-fuer-biontech-6171151
BioNTech on a restart course: Radical cut with an uncertain outcome
BioNTech on a restart course: Radical cut with an uncertain outcome: BioNTech has apparently already held confidential talks with interested parties about the ...
boerse-online.de/nachrichten/aktien/biontech-auf-neustart-kurs-radikaler-schnitt-mit-ungewissem-ausgang-20404154.html
BioNTech Marburg: From the Chancellor's visit to cancer therapy
BioNTech Marburg: From the Chancellor's visit to cancer therapy: BioNTech closes its Marburg site. A chronology: How BioNTech came to Marburg and what plans ...
mittelhessen.de/lokales/kreis-marburg-biedenkopf/marburg/biontech-marburg-von-kanzlerbesuch-bis-krebstherapie-5675448
First the windfall, then the crash: What the Biontech crisis means
First the windfall, then the crash: What the Biontech crisis means: Marburg was set to become part of Biontech’s once-legendary success story ...
capital.de/wirtschaft-politik/erst-der-millionenregen--dann-das-aus--was-die-biontech-misere-bedeutet-37378672.html
Biotech company halts Corona vaccine production in Germany
Biotech company halts Corona vaccine production in Germany: BioNTech halts coronavirus vaccine production in Germany and cuts up to 1,860 jobs ...
weltwoche.de/daily/biotechkonzern-stellt-corona-impfstoffproduktion-in-deutschland-ein/
BioNTech: Important data ahead
BioNTech: Important data ahead: The oncology pipeline is being further advanced.
deraktionaer.de/artikel/pharma-biotech/biontech-wichtige-daten-voraus-20397791.html
Scientists behind COVID-19 vaccine will depart BioNTech
Scientists behind COVID-19 vaccine will depart BioNTech: BioNTech’s stock closed 19% lower after its co-founders said they are leaving to start a new mRNA-based ...
marketwatch.com/story/scientists-behind-covid-19-vaccine-will-depart-biontech-ef157c79
Bayer sues COVID vaccine makers over mRNA technology
Bayer sues COVID vaccine makers over mRNA technology: Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on ...
reuters.com/legal/litigation/bayer-sues-covid-vaccine-makers-over-mrna-technology-2026-01-06/
Patents: Corona vaccines - | Bayer sues BioNTech, Pfizer and Moderna
Patents: Corona vaccines - | Bayer sues BioNTech, Pfizer and Moderna: Bayer accuses several manufacturers of copying an old technology to produce mRNA vaccines ...
handelsblatt.com/unternehmen/industrie/patente-corona-impfstoffe-bayer-verklagt-biontech-pfizer-und-moderna/100189227.html
BioNTech stock: Hope is back
BioNTech stock: Hope is back: BioNTech acquires CureVac and strengthens market position; blockbuster potential for new cancer drug BNT327.
boerse-online.de/nachrichten/aktien/biontech-aktie-die-hoffnung-ist-zurueck-20392023.html
Victory over the Corona pandemic: BioNTech gave the world hope five years ...
Victory over the Corona pandemic: BioNTech gave the world hope five years ago: Corona cost millions of lives in the pandemic year of 2020. On December 2nd ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/sieg-ueber-corona-biontech-gab-welt-vor-fuenf-jahren-hoffnung-5211328
Share swap - | Biontech launches offer to Curevac shareholders
Share swap - | Biontech launches offer to Curevac shareholders: The deadline for the share swap is December 3rd. The former competitors plan to conduct joint ...
stuttgarter-nachrichten.de/inhalt.aktientausch-biontech-startet-angebot-an-curevac-aktionaere.9753c233-bf64-4877-8fed-36fe7b77f02d.html
Antitrust authority approves BioNTech's acquisition of CureVac
Antitrust authority approves BioNTech's acquisition of CureVac: Why do competition watchdogs see no threat to innovation in the merger between BioNTech and ...
giessener-allgemeine.de/wirtschaft/kartellamt-erlaubt-kauf-von-curevac-durch-biontech-zr-93985421.html